Skip to content

Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS

Use of Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03673995
Enrollment
186
Registered
2018-09-17
Start date
2017-05-02
Completion date
2018-10-30
Last updated
2020-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirsutism, Menstrual Problem, Polycystic Ovary Syndrome

Brief summary

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.

Interventions

DIETARY_SUPPLEMENTMyo-inositol+L-tyrosine

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal, hirsutism and ovulation assesment.

Sponsors

Pharmarte srl
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 38 Years
Healthy volunteers
No

Inclusion criteria

° PCOS patients

Exclusion criteria

* thyroid dysfunction * hyperprolactinemia * adrenal hyperplasia * patients taking oral contraceptive * any other endocrinological pathologies

Design outcomes

Primary

MeasureTime frameDescription
Restore of regular menstrual period6 months of treatmentSelf report

Secondary

MeasureTime frameDescription
Improving hirsutism6 months of treatmentStandardised visual scales are preferred when assessing hirsutism, such as the modified Ferriman Gallwey score (mFG) with a level ≥ 4 - 6 indicating hirsutism,
Restore ovulation6 months of treatmentProgesterone value in luteal phase

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026